OBSS CodeMaster coding contest continues with Cambridge after Oxford
March 28, 2023 05:00 ET
|
OBSS TEKNOLOJI ANONIM SIRKETI
Business simulation coding contest takes place in world-class universities in the UK: Oxford, Cambridge and Imperial College, offering €30,000 grand prize Top 3 Oxford students received their prizes...
Surface Oncology Reports Financial Results and Corporate Highlights for Fourth Quarter and Full Year 2022
March 09, 2023 07:00 ET
|
Surface Oncology, Inc.
SRF388 clinical program advancing well; updated clinical data expected in the first half of 2023 First patient dosed in a Phase 1/2 study evaluating SRF114, a potential best-in-class anti-CCR8...
OBSS CodeMaster expands into the UK, coding contest takes place in Oxford & Cambridge with €30,000 grand prize
March 03, 2023 07:00 ET
|
OBSS TEKNOLOJI ANONIM SIRKETI
Software development and technology company OBSS Technology, conducts CodeMaster coding contest with a legacy of more than 10 years. On its 11th year, OBSS CodeMaster online coding contest expands...
LEX Diagnostics Appoints Scott O’Brien as LEX Board member
February 21, 2023 05:14 ET
|
LEX Diagnostics
CAMBRIDGESHIRE, United Kingdom, Feb. 21, 2023 (GLOBE NEWSWIRE) -- LEX Diagnostics (LEX) today announces the appointment of Scott O’Brien to the LEX Board. The company is revolutionising molecular...
Arden Group Selects View Smart Windows for Mixed-Use Residential Development at 4650 Broadway
January 26, 2023 07:00 ET
|
View, Inc.
View Smart Windows to be installed at a new mixed use development in Manhattan’s Inwood neighborhood, increasing natural light and access to views in apartment units and improving the health and...
BioNTech kündigt strategische Partnerschaft mit der Regierung des Vereinigten Königreichs an, um bis 2030 bis zu 10.000 Patientinnen und Patienten mit personalisierten mRNA-Krebsimmuntherapien zu behandeln
January 05, 2023 19:01 ET
|
BioNTech SE
Die mehrjährige Vereinbarung fokussiert sich auf drei strategische Bereiche: Krebsimmuntherapien, Impfstoffe gegen Infektionskrankheiten und weitere Expansion von BioNTech im Vereinigten...
BioNTech Announces Strategic Partnership with UK Government to Provide up to 10,000 Patients with Personalized mRNA Cancer Immunotherapies by 2030
January 05, 2023 19:01 ET
|
BioNTech SE
Multi-year collaboration focuses on three strategic pillars: cancer immunotherapies, infectious disease vaccines, and expansion of BioNTech’s footprint in the UKBioNTech aims to design and roll out...
RxCelerate Acquires Methuselah Health and Launches ProQuant™ World-Beating Proteomics Service
November 22, 2022 08:00 ET
|
RxCelerate
CAMBRIDGE, England, Nov. 22, 2022 (GLOBE NEWSWIRE) -- RxCelerate, a leading international out-sourced drug discovery and development platform, today announced the acquisition of drug discovery...
TILT Holdings’ Commonwealth Alternative Care Hosts Grand Opening at Newest Dispensary in Cambridge
September 16, 2022 07:30 ET
|
TILT Holdings Inc.
PHOENIX, Sept. 16, 2022 (GLOBE NEWSWIRE) -- TILT Holdings Inc. (“TILT” or the “Company”) (NEO: TILT) (OTCQX: TLLTF), a global provider of cannabis business solutions that include inhalation...
TILT Holdings Receives Approval to Launch Medical Use Cannabis Operations at its Cambridge, Massachusetts Dispensary
August 30, 2022 08:00 ET
|
TILT Holdings Inc.
PHOENIX, Aug. 30, 2022 (GLOBE NEWSWIRE) -- TILT Holdings Inc. (“TILT” or the “Company”) (NEO: TILT) (OTCQX: TLLTF), a global provider of cannabis business solutions that include inhalation...